Clinical Trial Update: A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial evaluating a new treatment approach for central nervous system nongerminomatous germ cell tumors in children and young adults. …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System Nongerminomatous Germ Cell Tumor
• Choriocarcinoma
• Embryonal Carcinoma
• Immature Teratoma
• Malignant Teratoma
• Mixed Germ Cell Tumor
• Pineal Region Germ Cell Tumor
• Suprasellar Germ Cell Tumor

Snippet

Sponsor: Children's Oncology Group | Conditions: Central Nervous System Nongerminomatous Germ Cell Tumor, Choriocarcinoma | Phase 2 | Status: RECRUITING